Runnymede Capital Advisors’s iShares US Medical Devices ETF IHI Stock Holding History

Runnymede Capital Advisors’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-3,459	Closed	-$208K	–	88
2025 Q3	$208K	Hold	3,459	–	–	0.17%	67
2025 Q2	$217K	Sell	3,459 -1,490	-30%	-$89.5K	0.2%	64
2025 Q1	$298K	Hold	4,949	–	–	0.29%	56
2024 Q4	$289K	Buy	+4,949	New	+$294K	0.25%	56

Other funds holding IHI

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

RIG

RiverFront Investment Group Richmond, Virginia $7.56B AUM 23.82% 1-Year Est. Return

Runnymede Capital Advisors's IHI Position: Q4 2025 in Review

Runnymede Capital Advisors sold out of iShares US Medical Devices ETF (IHI) in Q4 2025, closing a stake of 3,459 shares — an estimated $208K sold.

Runnymede Capital Advisors first reported a position in IHI in Q4 2024 and held it in 4 quarters. The position peaked at $298K in Q1 2025. 554 funds tracked by Wall St. Rank hold IHI as of Q4 2025.

Runnymede Capital Advisors reported no remaining iShares US Medical Devices ETF position as of Q4 2025 after selling out during the quarter.
Runnymede Capital Advisors sold 3,459 iShares US Medical Devices ETF shares in Q4 2025, an estimated $208K.
Runnymede Capital Advisors first reported a position in iShares US Medical Devices ETF in Q4 2024 and held it in 4 quarters.
Runnymede Capital Advisors's iShares US Medical Devices ETF position peaked at $298K in Q1 2025.
554 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q4 2025.

Based on Runnymede Capital Advisors's 13F filing for Q4 2025, filed 21 Jan 2026.